HKD 0.56
(-1.75%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -53.84 Million | 75.35 Million | -599.29 Million | 12.75 Million | 39.13 Million | -63.98 Million |
Net Income | -117.48 Million | 77.93 Million | 246.15 Million | 48.42 Million | 65.97 Million | 40.14 Million |
Depreciation & Amortization | 5.59 Million | 19.13 Million | 7.48 Million | 33.8 Million | 2.12 Million | 2.43 Million |
Deferred income taxes | - | - | -66.08 Million | -34.38 Million | - | -26.6 Million |
Stock-based compensation | 19.42 Million | 23.55 Million | 21.42 Million | 10.72 Million | - | 41.95 Million |
Change in working capital | -159 Thousand | -50.71 Million | -827.77 Million | -123.4 Million | -6.82 Million | -150.71 Million |
Other non-cash items | 7.36 Million | 5.43 Million | 19.49 Million | 77.59 Million | -22.14 Million | 28.8 Million |
Investing Cash Flow | -13.39 Million | -61.23 Million | -95.43 Million | 23.36 Million | -186.57 Million | -89.66 Million |
Investments in PPE | -2.4 Million | -2.98 Million | -1.82 Million | -2.56 Million | -130 Thousand | -2.15 Million |
Acquisitions | -13.02 Million | -15.75 Million | 2.66 Million | -47.27 Million | -93.68 Million | -15.3 Million |
Investment purchases | - | - | -23 Million | - | - | - |
Sales/Maturities of investments | - | - | 23.01 Million | - | - | 20.04 Million |
Other Investing Activities | -1.28 Million | -42.5 Million | -96.29 Million | 73.2 Million | -92.76 Million | -92.26 Million |
Financing Cash Flow | 13.96 Million | -109.88 Million | 901.59 Million | 7.12 Million | 102.53 Million | 97.64 Million |
Debt repayment | -30.9 Million | -305.6 Million | -186 Million | -282.5 Million | -73 Million | -690 Million |
Dividends payments | - | -60 Million | -40 Million | -1.5 Million | - | - |
Common Stock Repurchased | -289 Thousand | -28.12 Million | -19.38 Million | - | - | - |
Common Stock Issuance | 1000.00 | 1000.00 | 933.46 Million | - | - | - |
Other Financing Activities | 40 Thousand | 283.84 Million | 213.52 Million | 291.13 Million | 175.53 Million | 787.65 Million |
Accounts receivables | -33.29 Million | 252 Million | -393.69 Million | 49.59 Million | -306.58 Million | 107.59 Million |
Accounts payables | - | -252 Million | 393.69 Million | -49.59 Million | 306.58 Million | - |
Inventory | -212 Million | -10.19 Million | -228.41 Million | 66.43 Million | -260.39 Million | -235.97 Million |
Other working capital | 145.92 Million | -40.51 Million | -599.36 Million | -189.84 Million | 253.56 Million | 85.25 Million |
Cash at beginning of period | 208.04 Million | 302.79 Million | 95.59 Million | 52.34 Million | 97.25 Million | 153.25 Million |
Cash at end of period | 154.38 Million | 208.04 Million | 302.79 Million | 95.59 Million | 52.34 Million | 97.25 Million |
Capital Expenditure | -2.4 Million | -2.98 Million | -1.82 Million | -2.56 Million | -130 Thousand | -2.15 Million |
Effect of forex changes on cash | -380 Thousand | 1.02 Million | 331 Thousand | - | - | - |
Net cash flow / Change in cash | -53.66 Million | -94.74 Million | 207.19 Million | 43.24 Million | -44.9 Million | -56 Million |
Free Cash Flow | -56.25 Million | 72.37 Million | -601.12 Million | 10.18 Million | 39 Million | -66.13 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 14.94 Million | 14.94 Million | -117.48 Million | -55.32 Million | -55.32 Million | 666.5 Thousand |
Depreciation & Amortization | 1.68 Million | 1.68 Million | 5.59 Million | 1.54 Million | 1.54 Million | 1.25 Million |
Deferred income taxes | - | - | - | - | - | -85.54 Million |
Stock-based compensation | 3.92 Million | 3.92 Million | 19.42 Million | 4.68 Million | 4.68 Million | 5.02 Million |
Change in working capital | -51.44 Million | -51.44 Million | -159 Thousand | 24.8 Million | 24.8 Million | -74.49 Million |
Other non-cash items | 24.62 Million | 24.62 Million | 7.36 Million | 30.62 Million | 30.62 Million | 34.29 Million |
Investing Cash Flow | -9.4 Million | -9.4 Million | -13.39 Million | -6.64 Million | -6.64 Million | -52.5 Thousand |
Investments in PPE | -854.5 Thousand | -854.5 Thousand | -2.4 Million | -1.15 Million | -1.15 Million | -52.5 Thousand |
Acquisitions | - | - | -13.02 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -8.55 Million | -8.55 Million | -1.28 Million | -5.49 Million | -5.49 Million | - |
Financing Cash Flow | -8.8 Million | -8.8 Million | 13.96 Million | -27.47 Million | -27.47 Million | 34.45 Million |
Debt repayment | - | - | -30.9 Million | - | - | -38.9 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -289 Thousand | - | - | -144.5 Thousand |
Common Stock Issuance | - | - | 1000.00 | - | - | 1130.95 |
Other Financing Activities | -8.8 Million | -8.8 Million | 40 Thousand | -27.47 Million | -27.47 Million | 34.6 Million |
Accounts receivables | -173 Million | -173 Million | -33.29 Million | -1.54 Million | -1.54 Million | -15.1 Million |
Accounts payables | - | - | - | - | - | 73.43 Million |
Inventory | 130.71 Million | 130.71 Million | -212 Million | -55.55 Million | -55.55 Million | -50.45 Million |
Other working capital | -9.14 Million | -9.14 Million | 145.92 Million | 81.89 Million | 81.89 Million | -8.93 Million |
Cash at beginning of period | - | - | 208.04 Million | - | - | 282.08 Million |
Cash at end of period | -24.47 Million | -24.47 Million | 154.38 Million | -27.88 Million | -27.88 Million | 226.72 Million |
Capital Expenditure | -854.5 Thousand | -854.5 Thousand | -2.4 Million | -1.15 Million | -1.15 Million | -52.5 Thousand |
Effect of forex changes on cash | - | - | -380 Thousand | -101 Thousand | -101 Thousand | -89 Thousand |
Net cash flow / Change in cash | -24.47 Million | -24.47 Million | -53.66 Million | -27.88 Million | -27.88 Million | -55.36 Million |
Free Cash Flow | -7.11 Million | -7.11 Million | -56.25 Million | 5.18 Million | 5.18 Million | -33.31 Million |
1NBA
AXCP
BAJAJHIND
6349
JOHNPHARMA
GML